Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

Who hasn't played Bop It before? This childhood audio game toy took over most of my life when I was a small kid thanks to its loud, exciting music and the ability to play it competitively with friends ...

Hades 2 reviews are out, and not only is it currently surpassing the beloved original, but it's now the highest rated original game of 2025, beating out Clair Obscur: Expedition 33. Hades 2 reviews ...

The new season of Nebula‘s hit travel competition “Jet Lag: The Game” just debuted, so it’s going to be a few weeks until fans know which “All Stars” team came out victorious in the latest ...

Opendoor hired Shopify COO Kaz Nejatian as its new CEO, sending the stock soaring. Nejatian brings helpful experience with AI and scaling up Shopify's platform. While investors welcomed the news, ...

Monday night's loss to the Dolphins dropped the Jets to 0-4 this season and it was the third time that their self-inflicted wounds loomed large in a one-score loss. Head coach Aaron Glenn expressed ...

GameSpot may get a commission from retail offers. UFO 50 is celebrating its one-year anniversary today, September 18, 2025. Below, we reflect on how digesting the game week by week for an entire year ...

GameSpot may get a commission from retail offers. EA's skateboarding series, Skate, has been dormant since 2010's Skate 3, but it's officially back today with the launch of a reboot that's simply ...

Jack Peachey is a features writer who's worked at Dualshockers and Game Rant. An animation nerd, his favourite games don't have a genre in common as much as they all have pretty pictures. When not ...

Baby Steps, the "slapstick walking simulator about a slob climbing a mountain" co-developed by Bennett Foddy (the Getting Over It guy, which should give you a pretty good idea of what to expect), Gabe ...

The last time I spoke about Replimune (NASDAQ:REPL) it was with respect to a Seeking Alpha article entitled "Replimune: Scope Goes Beyond That of RP1 Oncolytic Targeting For Melanoma." With respect to ...